Janssen Infectious Diseases and Vaccines

Through science and innovation, Janssen Infectious Diseases & Vaccines aims to deliver solutions to prevent, treat and cure infectious diseases. Our efforts are focused on tackling the most complex infectious diseases, finding the right paths of intervention, and making sure they reach those in need. We have an ambitious goal—to ensure a future where we can prevent the spread of infectious diseases and eliminate the burden they place on global health.

BLUE KNIGHT™ is a joint initiative between Johnson & Johnson Innovation – JLABS (‘JLABS’) and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. This collaboration aims to stimulate the innovation and incubation of science and technologies that may improve health security and response by supporting companies focused on public health threats and emerging infectious diseases. In addition to connecting with the JLABS ecosystem, Blue Knight companies will be offered unique benefits, which can include fee assistance, cross-sector mentorship, JLABS space access and dedicated equipment. Learn more and apply to meet with Blue Knight by visiting our webpage.